Validation in type 2 diabetes of a metabolomic signature of all‐cause mortality

Circulating Metabolic Biomarkers Are Consistently Associated With Type 2 Diabetes Risk in Asian and European Populations

(2022) Jowy Yi Hoong Seah et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria

(2021) Signe Abitz Winther et al.   PLoS One

Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

(2020) Pouya Saeedi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The “Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes”: Study protocol

(2016) I. Barchetta et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics

(2015) Pasi Soininen et al.   Circulation-Cardiovascular Genetics

Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics

(2015) Pasi Soininen et al.   Circulation-Cardiovascular Genetics

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

(2013) David C. Goff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data

(2012) Hajime Uno et al.   STATISTICS IN MEDICINE

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE